Drugs for COVID-19

Two recombinant vaccines, Arexvy (GSK) and Abrysvo (Pfizer), have been approved by the FDA for prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in adults ≥60 years old. They are the first RSV vaccines to be approved in the US. Abrysvo is also approved for use in pregnant women at 32-36 weeks' gestation to prevent LRTD caused by RSV in their infants from birth through 6 months of age.

RSV DISEASE ― RSV typically causes a mild upper respiratory tract infection, but infants <6 months old and older adults, particularly those with...  Continue reading

Coming Soon
Drugs for Gout
Shockwave Therapy for Erectile Dysfunction
Antiviral Drugs for Influenza for 2023-2024
AD-Detect – A Blood Test for Alzheimer’s Disease